Consistent with the other cancer types mentioned above, EIF3B showed significantly higher expression in HNSCC and patients with elevated expression showed worse prognosis, indicating that EIF3B represents a risk factor in HNSCC prognosis. This evidence concerns the gene EIF3B and cancer.